Altimmune Newsroom

Jefferies Maintains Altimmune(ALT.US) With Buy Rating, Cuts Target Price to $28

Futu NewsJan 8 21:35

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Futu NewsJan 8 21:35

Evercore ISI Keeps Their Buy Rating on Altimmune (ALT)

TipRanksJan 8 21:23

Promising Prospects for Altimmune: Buy Rating Backed by Upcoming Data Readout and Strategic Expansion

TipRanksJan 8 21:18

Stifel Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $18

Futu NewsJan 8 20:37

Altimmune Analyst Ratings

BenzingaJan 8 18:02

Stifel Initiates Altimmune(ALT.US) With Buy Rating, Announces Target Price $18

Futu NewsJan 8 07:31

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20

Futu NewsDec 21, 2024 03:31

B.Riley Financial Keeps Their Buy Rating on Altimmune (ALT)

TipRanksDec 21, 2024 02:42

Altimmune Analyst Ratings

BenzingaNov 14, 2024 18:28

H.C. Wainwright Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 14, 2024 00:31

Altimmune's Pemvidutide Progress and Expansion: A Buy Recommendation by Patrick Trucchio

TipRanksNov 14, 2024 00:08

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 13, 2024 22:33

B.Riley Financial Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 13, 2024 21:31

Altimmune Analyst Ratings

BenzingaNov 12, 2024 21:48

UBS Initiates Altimmune(ALT.US) With Buy Rating, Announces Target Price $26

Futu NewsNov 12, 2024 18:37

Altimmune's Pemvidutide: A Promising Buy Rating for Metabolic Health Breakthroughs

TipRanksNov 12, 2024 18:14

Evercore Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 8, 2024 22:31

Analysts Are Bullish on Top Healthcare Stocks: Altimmune (ALT), Hansa Biopharma AB (SE:HNSA)

TipRanksOct 9, 2024 17:02

Piper Sandler Maintains Altimmune(ALT.US) With Buy Rating, Maintains Target Price $25

Futu NewsOct 4, 2024 20:31